<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Medical Device Courses | dag56 | Mentions</title>
	<link>https://medicaldevicecourses.com/members/dag56/activity/mentions/</link>
	<atom:link href="https://medicaldevicecourses.com/members/dag56/activity/mentions/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed mentioning dag56.</description>
	<lastBuildDate>Fri, 24 Apr 2026 18:20:46 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">e4d605d426e9b64f6bad9cd09b22dea1</guid>
				<title>yg385 replied to the topic  &#034;Discussion Topic: The Fifth &#034;P&#034; of Marketing&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/29887/</link>
				<pubDate>Sun, 20 Oct 2024 20:10:06 -0400</pubDate>

									<content:encoded><![CDATA[<p><a href='https://medicaldevicecourses.com/members/dag56/' rel="nofollow ugc">@dag56</a> , agree using a celebrity is definitely an effective tool that&#8217;s used in todays marketing to further connect with the intended audience. Another example of a celebrity very well used in Marketing is Ryan Reynolds in Mint Mobile ads&#8230;. &nbsp; <a href="https://medicaldevicecourses.com/forums/marketing-and-sales/discussion-topic-the-fifth-p-of-marketing/paged/7/#post-20141" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">3e371c31f458407121cf5b3f327c779d</guid>
				<title>thuytienlecao replied to the topic  &#034;Upper vs Middle Management.&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/14307/</link>
				<pubDate>Wed, 15 May 2019 18:54:58 -0400</pubDate>

									<content:encoded><![CDATA[<p>I personally perfer upper management because I tend to look at things in a big picture and for long term processes and I agree with <a href='https://medicaldevicecourses.com/members/dag56/' rel="nofollow ugc">@dag56</a> and @scott that to be a upper manager, you should have to have certain&#8230; &nbsp; <a href="https://medicaldevicecourses.com/community/organizational-development-in-device-companies/upper-vs-middle-management/#post-3979" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">4d4ca0b26495b04be9630e174bc36f7b</guid>
				<title>thuytienlecao replied to the topic  &#034;How to run a risk management meeting ?&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/14083/</link>
				<pubDate>Wed, 15 May 2019 18:51:45 -0400</pubDate>

									<content:encoded><![CDATA[<p>I agree with Mark about the formality, necessity, and process of a risk and with <a href='https://medicaldevicecourses.com/members/dag56/' rel="nofollow ugc">@dag56</a> about profit/risk scale. I think it would also be beneficial to have prior smaller meeting building up to this big scale meeting that Mark&#8230; &nbsp; <a href="https://medicaldevicecourses.com/community/risk-analysis-for-medical-devices/how-to-run-a-risk-management-meeting/#post-3755" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">40d57308f116417018cc73502dadd0a0</guid>
				<title>alexandrabuga replied to the topic  &#034;Clinical Studies&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/13736/</link>
				<pubDate>Wed, 15 May 2019 17:07:46 -0400</pubDate>

									<content:encoded><![CDATA[<p>I agree with <a href='https://medicaldevicecourses.com/members/reshamn/' rel="nofollow ugc">@reshamn</a> and <a href='https://medicaldevicecourses.com/members/dag56/' rel="nofollow ugc">@dag56</a> that there are many advantages to clinical trials including having patients have access to new treatments. At Sloan there are many clinical trials which include testing new drugs or drug combinations. As many have&#8230; &nbsp; <a href="https://medicaldevicecourses.com/community/clinical-research-basics/clinical-studies/paged/2/#post-3408" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">a8b48ec417b0418d2440e8fe4905aec6</guid>
				<title>alexandrabuga replied to the topic  &#034;Discussion Topic: Brand new biomaterial&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/12936/</link>
				<pubDate>Wed, 15 May 2019 17:00:31 -0400</pubDate>

									<content:encoded><![CDATA[<p>As many have mentioned like <a href='https://medicaldevicecourses.com/members/bb254/' rel="nofollow ugc">@bb254</a> and <a href='https://medicaldevicecourses.com/members/dag56/' rel="nofollow ugc">@dag56</a> before testing in clinical trials many tests need to be preformed. The biocompatibility testing needs to be performed in accordance with ISO 10993 including Cytotoxicity, Genotoxicity, Irritation, Systemic Tox, Hemocompatibility, Implantation, Toxikokinetics&#8230;. &nbsp; <a href="https://medicaldevicecourses.com/community/pre-clinical-device-development/discussion-topic-brand-new-biomaterial/#post-2608" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">8161c6bfe08c3aaa472350aa2f952a9d</guid>
				<title>thuytienlecao replied to the topic Upper vs Middle Management. in the forum Organizational Development in Device Companies</title>
				<link>https://medicaldevicecourses.com/activity/p/5348/</link>
				<pubDate>Mon, 27 Nov 2017 01:36:57 -0500</pubDate>

									<content:encoded><![CDATA[<p>I personally perfer upper management because I tend to look at things in a big picture and for long term processes and I agree with <a href='https://medicaldevicecourses.com/members/dag56/' rel="nofollow ugc">@dag56</a> and @scott that to be a upper manager, you should have to have certain experience in middle management. Also, I have read the article that <a href='https://medicaldevicecourses.com/members/kak33/' rel="nofollow ugc">@kak33</a> posted and actually agree with the opinion stated in the article&hellip;<span class="activity-read-more" id="activity-read-more-5348"><a href="https://medicaldevicecourses.com/activity/p/5348/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1bf3e0682f95aa4ceb82da885e61a7b9</guid>
				<title>jad73 replied to the topic Upper vs Middle Management. in the forum Organizational Development in Device Companies</title>
				<link>https://medicaldevicecourses.com/activity/p/5333/</link>
				<pubDate>Mon, 27 Nov 2017 00:29:57 -0500</pubDate>

									<content:encoded><![CDATA[<p>I think I can do both. I&#8217;m more suited starting out in a middle management role then transitioning to upper management. It goes in line with what @Scott said where upper managers would be best if they spent some time with the company as a middle manager. I think that being able to complete/fulfill a task on a daily/weekly basis is a fulfilling&hellip;<span class="activity-read-more" id="activity-read-more-5333"><a href="https://medicaldevicecourses.com/activity/p/5333/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">43004411a101158b38baffe70722517a</guid>
				<title>thuytienlecao replied to the topic What is Risk-benefit analysis ? in the forum Risk Analysis for Medical Devices</title>
				<link>https://medicaldevicecourses.com/activity/p/5128/</link>
				<pubDate>Fri, 17 Nov 2017 14:51:36 -0500</pubDate>

									<content:encoded><![CDATA[<p>I would like elaborate <a href='https://medicaldevicecourses.com/members/merzkrashed/' rel="nofollow ugc">@merzkrashed</a>&#8216;s point about the FDA article &#8220;Factors to Consider When Making Benefit-Risk Determinations in Medical Device Premarket Approval and De Novo Classifications&#8221;.<br />
When determining risk, the FDA assessing the severity, type, frequency, and length of harmful events. In addition, the FDA will also evaluate other&hellip;<span class="activity-read-more" id="activity-read-more-5128"><a href="https://medicaldevicecourses.com/activity/p/5128/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6993e683f0961a1a7a825806087f28a2</guid>
				<title>thuytienlecao replied to the topic How to run a risk management meeting ? in the forum Risk Analysis for Medical Devices</title>
				<link>https://medicaldevicecourses.com/activity/p/5110/</link>
				<pubDate>Tue, 14 Nov 2017 17:58:58 -0500</pubDate>

									<content:encoded><![CDATA[<p>I agree with Mark about the formality, necessity, and process of a risk and with <a href='https://medicaldevicecourses.com/members/dag56/' rel="nofollow ugc">@dag56</a> about profit/risk scale. I think it would also be beneficial to have prior smaller meeting building up to this big scale meeting that Mark has mentioned. For examples, a meeting between all the engineers and scientist and PM to draw up the risks before all the&hellip;<span class="activity-read-more" id="activity-read-more-5110"><a href="https://medicaldevicecourses.com/activity/p/5110/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f59a0fe15dd4a320b49bd14413ccded9</guid>
				<title>alexandrabuga replied to the topic Clinical Studies in the forum Clinical Research Basics</title>
				<link>https://medicaldevicecourses.com/activity/p/4597/</link>
				<pubDate>Sun, 29 Oct 2017 20:22:14 -0400</pubDate>

									<content:encoded><![CDATA[<p>I agree with <a href='https://medicaldevicecourses.com/members/reshamn/' rel="nofollow ugc">@reshamn</a> and <a href='https://medicaldevicecourses.com/members/dag56/' rel="nofollow ugc">@dag56</a> that there are many advantages to clinical trials including having patients have access to new treatments. At Sloan there are many clinical trials which include testing new drugs or drug combinations. As many have mentioned the patients understand the risks of entering a clinical trial, but especially in the&hellip;<span class="activity-read-more" id="activity-read-more-4597"><a href="https://medicaldevicecourses.com/activity/p/4597/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7fecdc643393c5400d7dcf3f90c1ef44</guid>
				<title>alexandrabuga replied to the topic Discussion Topic: Brand new biomaterial in the forum Pre-clinical Device Development</title>
				<link>https://medicaldevicecourses.com/activity/p/3391/</link>
				<pubDate>Thu, 21 Sep 2017 02:45:13 -0400</pubDate>

									<content:encoded><![CDATA[<p>As many have mentioned like <a href='https://medicaldevicecourses.com/members/bb254/' rel="nofollow ugc">@bb254</a> and <a href='https://medicaldevicecourses.com/members/dag56/' rel="nofollow ugc">@dag56</a> before testing in clinical trials many tests need to be preformed. The biocompatibility testing needs to be performed in accordance with ISO 10993 including Cytotoxicity, Genotoxicity, Irritation, Systemic Tox, Hemocompatibility, Implantation, Toxikokinetics. A urinary catheter is an example of a&hellip;<span class="activity-read-more" id="activity-read-more-3391"><a href="https://medicaldevicecourses.com/activity/p/3391/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>